Minerva Neurosciences | Passività Correnti





Passività Correnti Cambiamento Data
Acadia Pharmaceuticals USD 356.58M 26.56M 2025-09
Adma Biologics USD 56.49M 18.45M 2025-09
ALKERMES USD 474.36M 31.6M 2025-09
Alterity Therapeutics Limited AUD 4.38M 849.82K 2023-06
AstraZeneca USD 34.05B 518M 2025-09
BioCryst Pharmaceuticals USD 190.24M 13.08M 2025-09
Bristol-Myers Squibb USD 28.14B 608M 2025-09
Cipla INR 62.97B 8.13B 2025-09
Clal Biotechnology ILS 6.66M 3.75M 2023-12
Compugen USD 20.28M 300K 2025-09
CSL USD 4.82B 1.26B 2025-06
Dynavax Technologies USD 106.84M 11.39M 2025-09
Eli Lilly USD 40.14B 1.12B 2025-09
Esperion Therapeutics USD 359.03M 60.24M 2025-09
GlaxoSmithKline GBP 21.39B 57M 2025-12
Grifols EUR 2.53B 182.67M 2025-09
Halozyme Therapeutics USD 837.23M 702.95M 2025-09
Ionis Pharmaceuticals USD 903.46M 6.22M 2025-09
J&J USD 50.87B 3.31B 2025-09
Merck USD 28.63B 2.59B 2025-09
Minerva Neurosciences USD 2.67M 143K 2025-09
Neurocrine Biosciences USD 638M 91.7M 2025-09
Novartis USD 32B 286M 2025-09
Novavax USD 429.87M 40.73M 2025-09
Pfizer USD 36.6B 1.13B 2025-09
Roche Holding CHF 28B 421M 2025-12
Sanofi EUR 28.35B 3.76B 2025-12
Takeda JPY 2.61T 470.53B 2025-12
Vanda Pharmaceuticals USD 117.87M 3.62M 2025-09


Minerva Neurosciences Passività Correnti - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Feb 2026.